Journal ArticleDOI
Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization.
Reads0
Chats0
TLDR
The interesting properties of metformin such as radioprotection, radiomitigation and radiosensitization could make it an interesting adjuvant for clinical radiotherapy, as well as an interesting candidate for mitigation of radiation injury after a radiation disaster.Abstract:
BACKGROUND: Nowadays, ionizing radiation is used for several applications in medicine, industry, agriculture, and nuclear power generation. Besides the beneficial roles of ionizing radiation, there are some concerns about accidental exposure to radioactive sources. The threat posed by its use in terrorism is of global concern. Furthermore, there are several side effects to normal organs for patients who had undergone radiation treatment for cancer. Hence, the modulation of radiation response in normal tissues was one of the most important aims of radiobiology. Although, so far, several agents have been investigated for protection and mitigation of radiation injury. Agents such as amifostine may lead to severe toxicity, while others may interfere with radiation therapy outcomes as a result of tumor protection. Metformin is a natural agent that is well known as an antidiabetic drug. It has shown some antioxidant effects and enhances DNA repair capacity, thereby ameliorating cell death following exposure to radiation. Moreover, through targeting endogenous ROS production within cells, it can mitigate radiation injury. This could potentially make it an effective radiation countermeasure. In contrast to other radioprotectors, metformin has shown modulatory effects through induction of several genes such as AMPK, which suppresses reduction/ oxidation (redox) reactions, protects cells from accumulation of unrepaired DNA, and attenuates initiation of inflammation as well as fibrotic pathways. Interestingly, these properties of metformin can sensitize cancer cells to radiotherapy. CONCLUSION: In this article, we aimed to review the interesting properties of metformin such as radioprotection, radiomitigation and radiosensitization, which could make it an interesting adjuvant for clinical radiotherapy, as well as an interesting candidate for mitigation of radiation injury after a radiation disaster. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.read more
Citations
More filters
Journal ArticleDOI
Steps in metastasis: an updated review.
Jamal Majidpoor,Keywan Mortezaee +1 more
TL;DR: In this article, the tumor cells isolated from the primary tumor exploit several mechanisms to maintain their survival including rewiring metabolic demands to use sources available within the new environments, avoiding anoikis cell death when cells are detached from extracellular matrix (ECM), adopting flow mechanic by acquiring platelet shielding and immunosuppression by negating the activity of suppressor immune cells, such as natural killer (NK) cells.
Journal ArticleDOI
Radioprotection and Radiomitigation: From the Bench to Clinical Practice.
Elena Obrador,Rosario Salvador,J. I. Villaescusa,José Miguel Soriano,José M. Estrela,Alegría Montoro +5 more
TL;DR: Molecules under development with the aim of reaching clinical practice and other nonclinical applications are discussed and differentiates radioprotectors and radiomitigators (minimize toxicity even after radiation has been delivered).
Journal ArticleDOI
Targeting of oxidative stress and inflammation through ROS/NF-kappaB pathway in phosphine-induced hepatotoxicity mitigation
Hamed Haghi Aminjan,Seyed Reza Abtahi,Ebrahim Hazrati,Mohsen Chamanara,Maryam Jalili,Babak Paknejad +5 more
TL;DR: Targeting ROS/NF-kappaB signalling pathway by resveratrol may have a significant effect on the improvement of hepatic injury induced by phosphine, suggesting it may be a possible candidate for the treatment of phosphine-poisoning.
Journal ArticleDOI
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
TL;DR: The biology of metformin and its molecular mechanism of action is discussed, the existing cellular, pre-clinical, and clinical studies that have tested the anti-tumor potential of meetformin as a potential anti-cancer/anti-Tumor agent in breast cancer therapy are discussed, and the future prospects and directions for a better understanding and re-purposing of met formin as an anti- cancer drug in the treatment of breast cancer are outlined.
Journal ArticleDOI
Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer.
TL;DR: In this article, the authors investigated how desmoplastic aggregates can influence the functionality of CSCs for promoting a cold pancreatic tumor immunity, which can be an effective strategy for improving responses from cold tumors to immunotherapy.
References
More filters
Journal ArticleDOI
The histopathological evaluation of the effectiveness of melatonin as a protectant against acute lung injury induced by radiation therapy in a rat model.
TL;DR: The histopathological evidence regarding the effectiveness of melatonin as a protectant against acute lung injury induced by radiation therapy through restrained inflammation, regrettably at the expense of promoted fibrosis is put forward.
Journal ArticleDOI
Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair.
Zheng Wang,Zheng Wang,Songtao Lai,Songtao Lai,Ningyi Ma,Ningyi Ma,Yun Deng,Yong Liu,Dong-Ping Wei,Jian Dong Zhao,Jian Dong Zhao,Guo-Liang Jiang,Guo-Liang Jiang +12 more
TL;DR: The data suggest that metformin radiosensitizes pancreatic cancer cells in vitro via abrogation of the G2 checkpoint and inhibition of DNA damage repair, however, the in vivo study is needed to further confirm the findings from the in vitro study.
Journal ArticleDOI
Metformin Radiosensitizes p53-Deficient Colorectal Cancer Cells through Induction of G2/M Arrest and Inhibition of DNA Repair Proteins
TL;DR: In conclusion, metformin enhanced radiosensitivity by inducing G2/M arrest and reducing the expression of DNA repair proteins even in radioresistant HCT116 p53-/- colorectal cancer cells and tumors.
Journal ArticleDOI
STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α
Chi Zhang,Xi Yang,Qu Zhang,Qing Guo,Jia He,Qin Qin,Hongcheng Zhu,Jia Liu,Liangliang Zhan,Jing Lu,Zheming Liu,Liping Xu,Jianxin Ma,Shengbin Dai,Hongyan Cheng,Xinchen Sun +15 more
TL;DR: NSC74859 efficiently radiosensitized ESCC cells and xenografts in nude mice, and inhibited hypoxia-/radiation-induced activation of STAT3 and upregulation of HIF-1α and VEGF expression.
Journal ArticleDOI
Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy: Comparison of Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiation Therapy
TL;DR: The IMRT reduced the volume of bone marrow irradiated at the higher doses and the incidence and severity of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy.